4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-033648
Chief Commercial Officer sold 2,050 shares at $85.76 ($175,808)
- Chief Commercial Officer acquired 2,050 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hoerter Steven L. Chief Commercial Officer | 2018-05-23 | Option exercise | +2,050 | $39.76 | $81,508 | 2,050 | D |
| Hoerter Steven L. Chief Commercial Officer | 2018-05-23 | Sale | −2,050 | $85.76 | $175,808 | 0 | D |
| Derivatives | |||||||
| Hoerter Steven L. Chief Commercial Officer | 2018-05-23 | Option exercise · Stock option (right to buy) | −2,050 | 66,800 | D | ||
| Open-market sales · 2,050 sh · avg $85.76 · $175,808 | |||||||
Loading xslF345X03/doc4.xml…